Physician profile
Monta Hunter Wright
NPI 1790186328
$1,465.96
in general payments reported to CMS, 2019-2025
18 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $227 · 2024: $735 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $241.69 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $228.93 | 2023-2025 | |
| Novo Nordisk INC | $217.26 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $159.67 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.37 | 2023-2024 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Pfizer INC. | $98.92 | 2023-2025 | |
| Exact Sciences Corporation | $64.91 | 2023-2024 | Cologuard Collection Kit |
| Grifols USA, LLC | $64.49 | 2024-2025 | Prolastin-C Liquid |
| Gilead Sciences, INC. | $37.80 | 2025 | Epclusa |
| Bayer Healthcare Pharmaceuticals INC. | $29.97 | 2025 | |
| Abbott Laboratories | $29.32 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $29.10 | 2025 | Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $25.46 | 2025 | Spravato |
| Amgen INC. | $23.28 | 2025 | Evenity, Prolia |
| Phathom Pharmaceuticals, INC. | $19.56 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.38 | 2023 | Dificid |
| Nevro Corp. | $15.21 | 2023 | Senza |
| Glaxosmithkline, LLC. | $13.64 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monta Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.